MedPath

Laparoscopic Versus Open Left Colonic Resection

Phase 3
Completed
Conditions
Colon Cancer
Benign Disease
Interventions
Procedure: laparoscopic left colonic resection
Procedure: open left colonic resection
Registration Number
NCT00894725
Lead Sponsor
Università Vita-Salute San Raffaele
Brief Summary

The main goal of this study is to clarify if laparoscopy (LPS) could become the standard approach in patients undergoing left colonic resection.

268 patient candidates to left colonic resection were randomly assigned to LPS (n=134) or open (n=134) approach. Postoperative care protocol was the same in both groups. Trained members of the surgical staff who were not involved in the study registered 30-day postoperative morbidity. Cost-benefit analysis was based on hospital costs. Long-term morbidity, quality of life, and 5-year survival have also been evaluated.

Detailed Description

The study design was explained to the potential participants who were asked to sign a written informed consent before randomization.

Eligible patients were randomly allocated to LPS or open surgery. Randomization list was computer generated. Assignments were made by means of sealed sequenced masked envelopes which were opened, before the induction of anesthesia, by a nurse unaware of the trial design.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
268
Inclusion Criteria
  • age > 18 years
  • suitability to elective surgery
Exclusion Criteria
  • cancer infiltrating adjacent organs assessed by computed tomography
  • cardiovascular dysfunction (New York Heart Association class > 3)
  • respiratory dysfunction (arterial pO2 < 70 mmHg)
  • hepatic dysfunction (Child-Pugh class C)
  • ongoing infection
  • plasma neutrophil level < 2.0x109/L

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LPSlaparoscopic left colonic resectionlaparoscopic left colonic resection
Openopen left colonic resectionopen left colonic resection
Primary Outcome Measures
NameTimeMethod
short-term morbidity rate30 days
Secondary Outcome Measures
NameTimeMethod
long-term outcome5 years

Trial Locations

Locations (1)

San Raffaele Hospital, Surgical Department

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath